These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 8821628)

  • 1. CD3 and CD2 ligation alters CD49d epitope expression.
    Lin J; Qin L; Chavin KD; Ding Y; Punch JD; Yang Q; Burkly LC; Bromberg JS
    Pathobiology; 1995; 63(3):119-32. PubMed ID: 8821628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD2 monoclonal antibody-induced receptor changes. II. Interaction of CD2 and CD3.
    Lin J; Chavin KD; Qin L; Ding Y; Bromberg JS
    Cell Immunol; 1996 Feb; 167(2):249-58. PubMed ID: 8603434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2.
    Lin J; Yon RW; Chavin KD; Qin L; Woodward J; Ding Y; Yagita H; Bromberg JS
    Transplantation; 1995 Apr; 59(8):1162-71. PubMed ID: 7537394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects.
    Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
    Transplantation; 1993 Apr; 55(4):901-8. PubMed ID: 8097344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expression.
    Lin J; Gettys TW; Qin L; Chavin KD; Yang Q; Ding Y; Punch JD; Bromberg JS
    Pathobiology; 1995; 63(4):175-87. PubMed ID: 8866788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD2 and CD3 receptor-mediated tolerance: constraints on T cell activation.
    Punch JD; Lin J; Bluestone J; Bromberg JS
    Transplantation; 1999 Mar; 67(5):741-8. PubMed ID: 10096532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD2 is a dominant target for allogeneic responses.
    Bai Y; Fu S; Honig S; Wang Y; Qin L; Chen D; Bromberg JS
    Am J Transplant; 2002 Aug; 2(7):618-26. PubMed ID: 12201362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies against human T cell adhesion molecules--modulation of immune function in nonhuman primates.
    Berlin PJ; Bacher JD; Sharrow SO; Gonzalez C; Gress RE
    Transplantation; 1992 Apr; 53(4):840-9. PubMed ID: 1348883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of mice with anti-CD3 mAb induces endothelial vascular cell adhesion molecule-1 expression.
    Bergese SD; Pelletier RP; Ohye RG; Vallera DA; Orosz CG
    Transplantation; 1994 Mar; 57(5):711-7. PubMed ID: 7511256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation of CD11a-c/CD18, CD2 and RGD-binding receptors in endogenous and interleukin-2-stimulated NK activity of CD3-negative large granular lymphocytes.
    Timonen T; Gahmberg CG; Patarroyo M
    Int J Cancer; 1990 Dec; 46(6):1035-40. PubMed ID: 1979068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric scFv/gamma receptor-mediated T-cell lysis of tumor cells is coregulated by adhesion and accessory molecules.
    Weijtens ME; Willemsen RA; van Krimpen BA; Bolhuis RL
    Int J Cancer; 1998 Jul; 77(2):181-7. PubMed ID: 9650549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
    Chavin KD; Qin L; Lin J; Yagita H; Bromberg JS
    J Immunol; 1993 Dec; 151(12):7249-59. PubMed ID: 7903105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinants.
    Yang SY; Chouaib S; Dupont B
    J Immunol; 1986 Aug; 137(4):1097-100. PubMed ID: 2426350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
    Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
    Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a novel integrin beta 1 chain epitope and anti-beta 1 antibody-mediated enhancement of fibronectin binding are dependent on the stage of T cell differentiation.
    Wadsworth SA; Chang AC; Hong MJ; Halvorson MJ; Otto S; Coligan JE
    J Immunol; 1995 Mar; 154(5):2125-33. PubMed ID: 7532661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cultured human thymocytes lacking CD2 and CD11a/CD18 antigens are functional and adhere to endothelial cells via CD56 or CDw49d molecules.
    Poggi A; Zocchi MR
    Cell Immunol; 1992 Apr; 140(2):319-30. PubMed ID: 1371947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. Correlation with distinct alpha 4 epitopes.
    Pulido R; Elices MJ; Campanero MR; Osborn L; Schiffer S; García-Pardo A; Lobb R; Hemler ME; Sánchez-Madrid F
    J Biol Chem; 1991 Jun; 266(16):10241-5. PubMed ID: 1709929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination anti-CD2 and anti-CD3 monoclonal antibodies induce tolerance while altering interleukin-2, interleukin-4, tumor necrosis factor, and transforming growth factor-beta production.
    Chavin KD; Qin L; Lin J; Woodward JE; Baliga P; Bromberg JS
    Ann Surg; 1993 Oct; 218(4):492-501; discussion 501-3. PubMed ID: 8215640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cardiac allografts with established leukocyte infiltration by modulation of alpha4 (CD49d) and leukocyte function-associated antigen-1 (CD11a/CD18) integrin function.
    Chan BM; Zheng H; Wang H; Uniyal S; Garcia B; Wang J; Zhong R
    Transplantation; 1998 Aug; 66(3):277-83. PubMed ID: 9721793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival.
    Qin L; Chavin KD; Lin J; Yagita H; Bromberg JS
    J Exp Med; 1994 Jan; 179(1):341-6. PubMed ID: 7903681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.